SAFRICA-HEALTH-VIRUS-VACCINES-TRIAL
Michelle van Rooyen (R), a staff member gets ready to take a blood sample from a volunteer at the start of a clinical trial being set up by TASK, a clinical research organisation based in Cape Town, to see whether the Bacillus Calmette-Guerin (BCG) vaccine, which is given to babies in the country to protect them against tuberculosis, helps limit the damage caused by COVID-19, at a Hospital in Cape Town on May 4, 2020. Clinical trails start today at the hospital, where booster shots of the BCG vaccine will now be administered to 250 health workers and a placebo given to another 250. (Photo by RODGER BOSCH / AFP) (Photo by RODGER BOSCH/AFP via Getty Images)
PURCHASE A LICENCE
How can I use this image?
£375.00
GBP
DETAILS
Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Credit:
Editorial #:
1211734928
Collection:
AFP
Date created:
04 May, 2020
Upload date:
Licence type:
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_1QZ6WA
Max file size:
4000 x 2669 px (33.87 x 22.60 cm) - 300 dpi - 5 MB
- Tuberculosis Bacterium,
- Healthcare And Medicine,
- Vaccination,
- Assistance,
- Beginnings,
- Blood,
- Blood Test,
- Boundary,
- COVID-19,
- COVID-19 Vaccine,
- Cape Town,
- Damaged,
- Epidemic,
- Essential Services,
- Hospital,
- Illness,
- Infectious Disease,
- Medical Research,
- Moving Activity,
- Organised Group,
- Pandemic - Illness,
- Placebo Effect,
- Preparation,
- Research,
- South Africa,
- Virus Organism,
- Volunteer,
- Western Cape Province,